Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof
US7470668B2 · kind B2 · utility
21Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2005 |
| Grant date | Dec 30, 2008 |
| Priority date | — |
| Expiry date | Apr 4, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/035
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.